Skip to main content

Table 4 Response analysis based on sub-classification of histological features among clear cell tumours

From: High-dose interleukin2 – a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome

Number (%) “Favourable” N = 123 “Other” N = 21
A N = 83 B N = 33 C N = 7 D N = 3 E N = 3 F N = 5 G N = 10
Papillary <10 % NO NO NO
Alveolar or solid >50 % NO NO NO NO
Granular <50 % NO NO NO
ORR 42 (50.6) 13 (39.4) 3 (42.9) 2 (66.7) 0 (0) 0 (0) 1 (10.0)
CR 19 (22.9) 7 (21.2) 1 (14.3) 2 (66.7) 0 (0) 0 (0) 0 (0)
PR 23 (27.8) 6 (18.2) 2 (28.6) 0 (0) 0 (0) 0 (0) 1 (10.0)
SD 25 (30.1) 8 (24.2) 2 (28.6) 1 (33.3) 2 (66.7) 2 (40.0) 6 (60.0)
PD 16 (19.3) 12 (36.4) 2 (28.6) 0 (0) 1 (33.3) 3 (60.0) 3 (30.0)
  1. Note: One patient with Type II Papillary carcinoma who achieved CR was excluded from this analysis